No Data
Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday
Personalis Shares Are Trading Higher After the Company and Moderna Recently Announced a Multi-year Extension to Continue Utilizing the Personalis ImmunoID NeXT Platform and Technology for V940/mRNA-4157. The Company Also Announced an Investment From...
Personalis Price Target Maintained With a $7.25/Share by Needham
Personalis Price Target Raised to $8 From $7 at BTIG
Personalis Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Personalis, Raises Price Target to $11